New hope for tough lymphoma: glofitamab under Real-World microscope

This study looks at how well the drug glofitamab works for people with a type of blood cancer called diffuse large B-cell lymphoma that did not respond to or came back after initial treatment. About 20 adults will take part, and their doctors will decide if they get glofitamab alone or with other drugs. The goal is to see how many patients have their tumors shrink or disappear, while also tracking side effects and using a blood test to check for leftover cancer cells.